Alemtuzumab is not superior to basiliximab to prevent acute antibody-mediated rejection (AMR) after simultaneous pancreas-kidney transplantation
Conference Paper
Full Text
Duke Authors
Cited Authors
- Pirsch, JD; Pascual, J; Sasmaniego, MD; Torrealba, JR; Odorico, JS; Becker, YT; Fernandez, LA; Knechtle, SJ; Sollinger, HW
Published Date
- September 1, 2007
Published In
Volume / Issue
- 14 / 5
Start / End Page
- 381 - 381
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0908-665X
Conference Name
- Joint Meeting of the International-Xenotransplantation-Association/International-Pancrcas-and-Islet-Transplant-Association/Cell-Transplant-Society
Conference Location
- Minneapolis, MN
Conference Start Date
- September 15, 2007
Conference End Date
- September 20, 2007